• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Johnson & Johnson to keep a 9.5% stake in consumer health spinoff Kenvue stake after...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 21, 2023 at 07:02: PM
via After Johnson & Johnson initiated a share-exchange offer to significantly reduce its holdings in Kenvue, the company says it's keeping about a 9.5% stake in the consumer health spinoff.

article source
 

<



Similar threads

cafead
Johnson &amp; Johnson adds $1.1 billion to proposed talc settlement
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Targeting AZ&#039;s Tagrisso, Johnson &amp; Johnson&#039;s Rybrevant combo wins key FDA nod in first-line lung cancer
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson boosts full-year outlook on strong Q2 sales numbers
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson proposes $505M settlement with bankrupt talc miners
Replies
0
Views
55
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
How Pfizer, Bristol Myers Squibb and Johnson &amp; Johnson Are Confronting Patent Cliffs
Replies
0
Views
51
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote